GlassScriptPhysician profile
Jillian R Lapham
NPI 1841851698
$641.96
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $35.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $68.79 | 2021 | |
| Foundation Medicine, INC. | $60.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $51.74 | 2021 | |
| Jazz Pharmaceuticals INC. | $44.00 | 2021 | |
| Merck Sharp & Dohme LLC | $39.03 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.45 | 2021 | |
| Genzyme Corporation | $35.18 | 2021 | |
| Janssen Biotech, INC. | $34.25 | 2021-2022 | |
| Morphosys, US INC. | $31.03 | 2021 | |
| Celgene Corporation | $27.36 | 2021 | |
| Eusa Pharma (US) LLC | $22.19 | 2021 | |
| Eisai INC. | $22.03 | 2021 | |
| Taiho Oncology, INC. | $17.36 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.30 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $15.62 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $15.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.26 | 2021 | |
| Karyopharm Therapeutics INC. | $14.07 | 2021 | |
| Glaxosmithkline, LLC. | $14.03 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.64 | 2021 | |
| Coherus Oncology, INC. | $12.68 | 2021 | |
| Seagen INC. | $12.24 | 2021 | |
| Beigene USA, INC. | $12.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.93 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Lapham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.